MolecuLight Appoints Dr. Julia Wright as Chief Medical Officer to Accelerate Clinical Adoption

MolecuLight Inc. Ontario

is a privately owned medical imaging company with a global presence that manufactures and commercializes the MolecuLight i:X® and DX™ wound imaging devices. These are the only Class II FDA-cleared point-of-care imaging devices for the real-time detection of elevated bacterial burden in wounds. They also provide accurate digital wound measurement for comprehensive wound management, supported by strong clinical evidence including over 100 peer-reviewed publications.

www.moleculight.com

Photo - https://mma.prnewswire.com/media/2728156/MolecuLight_MolecuLight_Appoints_Dr__Julia_Wright_as_Chief_Medic.jpg
Photo - https://mma.prnewswire.com/media/2728155/MolecuLight_MolecuLight_Appoints_Dr__Julia_Wright_as_Chief_Medic.jpg

View original content:https://www.prnewswire.co.uk/news-releases/moleculight-appoints-dr-julia-wright-as-chief-medical-officer-to-accelerate-clinical-adoption-302501749.html